Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.
One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback